JPWO2023100910A1 - - Google Patents

Info

Publication number
JPWO2023100910A1
JPWO2023100910A1 JP2023565037A JP2023565037A JPWO2023100910A1 JP WO2023100910 A1 JPWO2023100910 A1 JP WO2023100910A1 JP 2023565037 A JP2023565037 A JP 2023565037A JP 2023565037 A JP2023565037 A JP 2023565037A JP WO2023100910 A1 JPWO2023100910 A1 JP WO2023100910A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023565037A
Other languages
Japanese (ja)
Other versions
JPWO2023100910A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023100910A1 publication Critical patent/JPWO2023100910A1/ja
Publication of JPWO2023100910A5 publication Critical patent/JPWO2023100910A5/ja
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/966Elastase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/067Pancreatitis or colitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2023565037A 2021-11-30 2022-11-30 Pending JPWO2023100910A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021194361 2021-11-30
PCT/JP2022/044078 WO2023100910A1 (ja) 2021-11-30 2022-11-30 糞便中エラスターゼ1を測定する方法

Publications (2)

Publication Number Publication Date
JPWO2023100910A1 true JPWO2023100910A1 (https=) 2023-06-08
JPWO2023100910A5 JPWO2023100910A5 (https=) 2025-10-09

Family

ID=86612196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565037A Pending JPWO2023100910A1 (https=) 2021-11-30 2022-11-30

Country Status (6)

Country Link
US (1) US20250035630A1 (https=)
EP (1) EP4443160A4 (https=)
JP (1) JPWO2023100910A1 (https=)
KR (1) KR20240108487A (https=)
CN (1) CN118401838A (https=)
WO (1) WO2023100910A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617299B2 (ja) * 1986-09-17 1997-06-04 ダイナボット 株式会社 エラスターゼ1の免疫学的測定方法
JPH0525715Y2 (https=) 1986-10-31 1993-06-29
JPH03215747A (ja) * 1990-01-19 1991-09-20 Maruko Seiyaku Kk エラスターゼ1の酵素免疫学的測定方法および測定用試薬
DE4107765A1 (de) * 1990-07-28 1992-01-30 Schebo Tech Medizinisch Biolog Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt
JP4530539B2 (ja) * 1998-09-08 2010-08-25 プリファテス インスティトゥット バイオサルフ ゲーエムベーハー 膵機能障害認識のための診断方法
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
JPWO2002079782A1 (ja) 2001-03-30 2004-07-22 株式会社三菱化学ヤトロン エラスターゼ1の免疫分析用試薬及び免疫分析方法並びに膵疾患の検出方法
EP2947459B1 (en) 2014-05-21 2017-07-12 Bühlmann Laboratories AG Method for determination of a protein

Also Published As

Publication number Publication date
WO2023100910A1 (ja) 2023-06-08
EP4443160A4 (en) 2025-11-19
CN118401838A (zh) 2024-07-26
EP4443160A1 (en) 2024-10-09
KR20240108487A (ko) 2024-07-09
US20250035630A1 (en) 2025-01-30

Similar Documents

Publication Publication Date Title
JPWO2023100910A1 (https=)
CN305782261S (https=)
CN305788556S (https=)
CN305536692S (https=)
CN305534857S (https=)
CN305534576S (https=)
CN305533506S (https=)
CN305533433S (https=)
CN305533199S (https=)
CN305532731S (https=)
CN305529337S (https=)
CN305529217S (https=)
CN306617959S (https=)
CN306173602S (https=)
CN305838934S (https=)
CN305837950S (https=)
CN305837376S (https=)
CN305836048S (https=)
CN305833069S (https=)
CN305798580S (https=)
CN305794365S (https=)
CN305791723S (https=)
CN305630360S (https=)
CN305782906S (https=)
CN305780323S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251001

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251001